G Fonseca - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

G Fonseca

Showing results (301-310 of 303) with videos related to

Pageof 31

Sort By:

You have reached the last page of results.This site can display upto 303 results.

Viruses|September 28, 2023

B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from PatientsFernanda F Ramos, Isabela A G Pereira, Mariana M Cardoso, et al.

American Journal of Medical Genetics. Part A|June 26, 2024

Low-pass whole genome sequencing as a cost-effective alternative to chromosomal microarray analysis for low- and middle-income countriesPatricia C Mazzonetto, Darine Villela, Ana C V Krepischi, et al.

Iscience|November 1, 2021

Polyclonal F(ab')<sub>2</sub> fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potencyLuis Eduardo R Cunha, Adilson A Stolet, Marcelo A Strauch, et al.

Pageof 31

Search research articles

Showing results (301-310 of 303) with videos related to

Sort By:

Pageof 31

You have reached the last page of results.This site can display upto 303 results.

Viruses|September 28, 2023

B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from PatientsFernanda F Ramos, Isabela A G Pereira, Mariana M Cardoso, et al.

American Journal of Medical Genetics. Part A|June 26, 2024

Low-pass whole genome sequencing as a cost-effective alternative to chromosomal microarray analysis for low- and middle-income countriesPatricia C Mazzonetto, Darine Villela, Ana C V Krepischi, et al.

Iscience|November 1, 2021

Polyclonal F(ab')<sub>2</sub> fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potencyLuis Eduardo R Cunha, Adilson A Stolet, Marcelo A Strauch, et al.

Pageof 31